Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02905643
What this trial is testing

Discerning Pseudoprogression vs True Tumor Growth in GBMs

Who this might be right for
Glioblastoma
Ascension Health 1
Testing effectiveness (Phase 2)Looking for participantsNCT06132685
What this trial is testing

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Who this might be right for
Low Grade GliomaMalignant Brain GliomaMalignant Brain Neoplasm+1 more
Emory University 200
Not applicableNot Yet RecruitingNCT06617208
What this trial is testing

Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery

Who this might be right for
GliomaGlioblastoma (GBM)Brain Tumor-Glioma
Erasmus Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT01884740
What this trial is testing

Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

Who this might be right for
Glioblastoma MultiformeFibrillary Astrocytoma of BrainGlioma of Brainstem+5 more
Weill Medical College of Cornell University 13
Not applicableUnknownNCT05593809
What this trial is testing

Single Photon Emission Computed Tomography/Computed Tomography With Pentavalent 99mTc Dimercaptosuccinic Acid in Patients With Brain Glioma; Correlation With IDH Mutation

Who this might be right for
Brain Glioma
Assiut University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06687681
What this trial is testing

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Who this might be right for
Glioma Glioblastoma MultiformeHigh Grade Glioma (III or IV)
Marzieh Ebrahimi 40
Testing effectiveness (Phase 2)Study completedNCT00004068
What this trial is testing

Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 53
Early research (Phase 1)Active Not RecruitingNCT03605550
What this trial is testing

A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine Glioma
Nationwide Children's Hospital 64
Large-scale testing (Phase 3)Study completedNCT00002840
What this trial is testing

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 350
Not applicableEnded earlyNCT01954576
What this trial is testing

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaBrain Neoplasms
University of Florida 21
Large-scale testing (Phase 3)Looking for participantsNCT05230758
What this trial is testing

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour

Who this might be right for
Medulloblastoma, ChildhoodCognitive Impairment
Donald Mabbott 140
Large-scale testing (Phase 3)Study completedNCT00003293
What this trial is testing

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Not applicableWithdrawnNCT02194452
What this trial is testing

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Who this might be right for
Acoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+92 more
Sue O'Dorisio
Early research (Phase 1)Study completedNCT00612638
What this trial is testing

Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas

Who this might be right for
GlioblastomaGliosarcoma
Duke University 96
Early research (Phase 1)Ended earlyNCT01902771
What this trial is testing

Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

Who this might be right for
GliomaBrain CancerBrain Tumor+2 more
Edward Ziga 1
Testing effectiveness (Phase 2)Looking for participantsNCT05664464
What this trial is testing

Glutamate Inhibitors in Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 120
Not applicableLooking for participantsNCT05464992
What this trial is testing

Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI

Who this might be right for
GliomaBrain Metastases
Centre Paul Strauss 800
Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)WithdrawnNCT00021307
What this trial is testing

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01026493
What this trial is testing

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 257
Next Page